CASSAVA SCIENCES INC (SAVA) Stock Income Statement
NASDAQ:SAVA - Nasdaq - US14817C1071 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 141.45M | 105.96M | 80.02M | 32.87M | 6.80M | |||
| Research and Development | 69.64M | 89.42M | 7.26M | 5.94M | N/A | |||
| Selling, General, and Administrative Expenses | 71.81M | 16.53M | 11.99M | 8.06M | 3.74M | |||
| Operating Income | -141.45M | -105.96M | -80.02M | -32.87M | -6.80M | |||
| Interest Income/Expense | 8.51M | 7.83M | 2.78M | 50.00K | 110.00K | |||
| Other Income/Expense | 108.59M | 907.00K | 1.00M | 430.00K | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 350.00K | |||
| Income Before Taxes | -24.34M | -97.22M | -76.25M | -32.39M | -6.33M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -24.34M | -97.22M | -76.25M | -32.39M | -6.33M | |||
| EBITDA | -140.31M | -104.43M | -78.72M | -32.37M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.53 | -2.32 | -1.90 | -0.82 | -0.24 | |||
| Non GAAP EPS | -1.45 | -2.32 | -1.90 | -0.81 | -0.25 | |||
| Statistics | ||||||||
All data in USD